PRINCETON, N.J., May 24, 2021 /PRNewswire/ — Sandoz today announced Treprostinil Injection, a generic Remodulin (R), is now also available for subcutaneous (“SC”) administration to treat patients ...
DUBLIN, April 22, 2024 /PRNewswire/ -- Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven ...
(RTTNews) - Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the ...
A single lot of Treprostinil injection is being recalled by manufacturer Par Pharmaceutical Inc based on concerns about the potential for silicone particulates to be present in the product solution, ...
Par Pharmaceuticals is recalling 1 lot of Treprostinil Injection 20mg/20mL (1mg/mL) due to the potential for the presence of silicone particulates in the product solution. Treprostinil is a ...
PRINCETON, N.J., March 25, 2019 /PRNewswire/ -- Sandoz today announced the US availability of Treprostinil Injection, the first fully substitutable AP rated generic version of Remodulin ®* ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
The stability of treprostinil sodium after dilution in three common i.v. infusion vehicles was assessed. The chemical stability of treprostinil sodium was tested over a 48-hour period at 40 °C and 75% ...
DUBLIN, March 12, 2024 /PRNewswire/ -- Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results